Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Director departure
Quarterly results
CC transcript
Asset disposition
Inv. presentation

HARVARD BIOSCIENCE INC (HBIO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/21/2023 4 Green James W (CEO) has filed a Form 4 on HARVARD BIOSCIENCE INC
Txns: Bought 25,000 shares @ $4.38, valued at $109.5k
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Q2 Revenues of $28.8 million"
05/23/2023 4 EDRICK ALAN I (Director) has filed a Form 4 on HARVARD BIOSCIENCE INC
Txns: Granted 25,554 shares @ $0
05/23/2023 4 Eade Katherine A. (Director) has filed a Form 4 on HARVARD BIOSCIENCE INC
Txns: Granted 25,554 shares @ $0
05/23/2023 4 Loewald Thomas W (Director) has filed a Form 4 on HARVARD BIOSCIENCE INC
Txns: Granted 25,554 shares @ $0
05/23/2023 4 LOY BERTRAND (Director) has filed a Form 4 on HARVARD BIOSCIENCE INC
Txns: Granted 31,516 shares @ $0
04/26/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/05/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/16/2023 4 EDRICK ALAN I (Director) has filed a Form 4 on HARVARD BIOSCIENCE INC
Txns: Bought 13,808 shares @ $2.67, valued at $36.9k
Bought 16,192 shares @ $2.62, valued at $42.4k
03/15/2023 4 Green James W (CEO) has filed a Form 4 on HARVARD BIOSCIENCE INC
Txns: Bought 20,000 shares @ $2.67, valued at $53.4k
Bought 20,000 shares @ $2.6, valued at $52k
03/13/2023 8-K Other Events  Interactive Data
03/10/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/09/2023 10-K Annual Report for the period ended December 31, 2022
03/09/2023 8-K Quarterly results
Docs: "Harvard Bioscience Announces Fourth Quarter 2022 Financial Results HOLLISTON, Mass., March 9, 2023"
03/08/2023 4 Green James W (CEO) has filed a Form 4 on HARVARD BIOSCIENCE INC
Txns: Granted 353,140 shares @ $0
Granted 339,610 shares @ $0
03/08/2023 4 Cote Jennifer (Interim CFO) has filed a Form 4 on HARVARD BIOSCIENCE INC
Txns: Granted 26,892 shares @ $0
Granted 25,862 shares @ $0
Granted 29,880 shares @ $0
02/14/2023 SC 13G Harvey Partners, LLC reports a 7% stake in HARVARD BIOSCIENCE, INC.
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/19/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "SEPARATION AGREEMENT AND RELEASE"
01/11/2023 SC 13G/A Leviticus Partners LP reports a 4.9% stake in HARVARD BIOSCIENCE INC
01/03/2023 3 Cote Jennifer (Interim CFO) has filed a Form 3 on HARVARD BIOSCIENCE INC
01/03/2023 4 Rossi Michael A. (CFO) has filed a Form 4 on HARVARD BIOSCIENCE INC
Txns: Paid exercise price by delivering 3,162 shares @ $2.55, valued at $8.1k
Paid exercise price by delivering 3,763 shares @ $2.55, valued at $9.6k
Paid exercise price by delivering 3,035 shares @ $2.55, valued at $7.7k
01/03/2023 4 Green James W (CEO) has filed a Form 4 on HARVARD BIOSCIENCE INC
Txns: Paid exercise price by delivering 24,187 shares @ $2.55, valued at $61.7k
Paid exercise price by delivering 28,784 shares @ $2.55, valued at $73.4k
Paid exercise price by delivering 23,216 shares @ $2.55, valued at $59.2k
Paid exercise price by delivering 49,322 shares @ $2.77, valued at $136.6k
01/03/2023 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Vice President, Finance"
12/21/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/12/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Harvard Bioscience Announces CFO Transition"
12/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
Docs: "Harvard Bioscience Announces Third Quarter 2022 Financial Results"
09/15/2022 4 LOY BERTRAND (Director) has filed a Form 4 on HARVARD BIOSCIENCE INC
Txns: Disposed of 108,715 shares @ $0
08/29/2022 4 LOY BERTRAND (Director) has filed a Form 4 on HARVARD BIOSCIENCE INC
Txns: Bought 9,291 shares @ $3.41, valued at $31.7k
08/26/2022 4 LOY BERTRAND (Director) has filed a Form 4 on HARVARD BIOSCIENCE INC
Txns: Bought 17,291 shares @ $3.23, valued at $55.8k
Bought 8,244 shares @ $3.34, valued at $27.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy